about
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene gre...
Read More
25.72
0.77
(3.09%)
121.1K
XNAS Volume
XNAS 16 Jul, 2025 11:01 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Cg Oncology Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..